- Home
- HYMC vs ANGO Comparison
HYMC vs ANGO Comparison
Compare HYMC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$28.40
HOLD
Current Price
$13.34
Company Overview
Basic Information| Metric | HYMC | ANGO |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 648.5M | 530.2M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | HYMC | ANGO |
|---|---|---|
| Price | $28.40 | $13.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | ★ 4.5M | 376.2K |
| Earning Date | 10-28-2025 | 01-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $300,718,000.00 |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $2.00 | $8.27 |
| 52 Week High | $29.80 | $13.99 |
Technical Indicators
Market Signals| Indicator | HYMC | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 81.19 | 56.45 |
| Support Level | $22.35 | $12.44 |
| Resistance Level | $24.90 | $13.12 |
| Average True Range (ATR) | 2.64 | 0.40 |
| MACD | 0.67 | -0.08 |
| Stochastic Oscillator | 92.06 | 61.90 |
Price Performance
Historical Comparison HYMC
ANGO
About HYMC Hycroft Mining Holding Corporation
Hycroft Mining Holding Corp is a gold and silver producer. Its operating mine, the Hycroft Mine, is an open-pit heap leach operation located approximately fifty four miles west of Winnemucca, Nevada.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.